Tagala, Crisanta .
HRN: 27-20-80 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2025
CEFUROXIME 500MG (TAB)
05/29/2025
06/04/2025
ORAL
500mg
BID
Sp NSVD With RMLE
Checking Initial Appropriateness